Quince Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-33.3M | $-33.3M | $55.0K | $2.1M |
| FY2020 | $-50.8M | $-50.9M | $52.0K | $14.5M |
| FY2021 | $-62.9M | $-63.1M | $180.0K | $29.9M |
| FY2022 | $-44.0M | $-44.2M | $133.0K | $16.6M |
| FY2023 | $-18.3M | $-18.5M | $160.0K | $5.2M |
| FY2024 | $-31.9M | $-32.2M | $257.0K | $4.7M |
| FY2025 | $-41.4M | $-41.8M | $352.0K | $5.1M |